Fluence Announces Strawberry Research Results, Revealing Higher Yields and Better Plant Quality Under Broad-Spectrum Lighting Strategies
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced results from its year-long strawberry research in collaboration with Delphy Improvement Centre (Delphy), an independent institute and expert in food and flowers located in Bleiswijk, the Netherlands. Together, Fluence and Delphy studied how Fluence’s LED lighting solutions impact strawberry production in greenhouses.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220127005243/en/
Fluence and Delphy researchers analyzed morphology, yield and quality for Sonata and Sonsation cultivars—two of the most popular strawberry cultivars in Europe—under four spectral strategies. Overall, during the winter flush, spectra that included a fraction of far-red saw increased performance across all categories. However, the white spectrum with a fraction of far-red recorded the best performance across categories. (Photo: Business Wire)
As grocers push produce suppliers to deliver fresh, high-quality crops year-round, growers are increasingly exploring how to allocate high-tech greenhouse space to strawberries, which are typically grown outdoors or in hoop houses (small, semi-portable structures). Fluence and Delphy examined how to sustainably grow strawberry crops in high-tech greenhouse environments while maximizing yield and fruit quality.
“Results from our collaboration with Delphy are showing that strawberries thrive under predominantly white spectra, creating opportunities for greenhouse growers to introduce new, efficient lighting strategies into their facilities,” said David Hawley, Ph.D, principal scientist for Fluence. “Strawberry cultivars grown under a broad-spectrum with a fraction of far-red saw taller crops, wider canopies, higher overall yields and increased Brix values. As with all crops and individual cultivars, there is no ubiquitous lighting strategy for optimizing plant yield and quality. However, our global research endeavors continue to showcase the power of optimized lighting solutions for the world’s most popular crops.”
Fluence and Delphy researchers analyzed morphology, yield and quality for Sonata and Sonsation cultivars—two of the most popular cultivars in Europe—under four spectral strategies: white (Fluence PhysioSpec™ R4), white with a fraction of far-red (R4 + FR), pink (R8), and pink with the same fraction of far-red (R8 + FR). Overall, during the winter flush, spectra that included a fraction of far-red saw increased performance across all categories. However, the white spectrum with a fraction of far-red recorded the best performance across categories:
- Sonata and Sonsation cultivars saw 68% and 40% taller crops as well as 28% and 29% wider canopies, respectively, under a white spectrum with a fraction of far-red in relation to a pink spectrum. Taller and wider crops are easier to harvest and enable better air movement across plants, discouraging pathogens that would thrive in more dense, humid environments.
- Similarly, Sonata and Sonsation cultivars grown under a white spectrum with a fraction of far-red saw 11% and 14% higher cumulative yields (including plant “waste” that can be used for jams, juice or preserves) relative to those grown under a pink spectrum.
- Researchers also reported that Sonata and Sonsation cultivars grown under a white spectrum with a fraction of far-red had 14% and 6% higher Brix values, respectively, than cultivars grown under a pink spectrum.
“Produce managers at grocers and other retailers seek quality and consistency from their suppliers—consistency that a high-tech greenhouse facility is built to provide,” said David Cohen, CEO of Fluence. “Greenhouses create safe, clean and controlled environments. With an optimized lighting strategy, growers can produce crops with delicious flavors that consumers demand and yields that enable store shelves to remain stocked year-round.”
For more information on Fluence and the company’s ongoing research initiatives, visit www.fluence.science.
About Fluence by OSRAM
Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM, creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. For more information about Fluence, visit https://fluence.science.
About Delphy Improvement Centre
Delphy Improvement Centre, located Bleiswijk, the Netherlands, is a recognized research institute that executes cultivation-related trials in all kinds of crops. The experiments are performed in a modern greenhouse complex located in close proximity to their target audience: The growers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220127005243/en/
Contact information
For Fluence,
Emma Chase
pr@fluencebioengineering.com
C: 512-917-4319
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
